Early diagnosis of RA

The kit is intended as an aid in the early diagnosis of rheumatoid arthritis, measuring specific IgG autoantibodies against secondgeneration cyclic citrullinated peptides (CCP2) in human serum.

In common with all BINDAZYME assays, the new anti-CCP2 kit is automation friendly and easy to use. Its single-well ‘break apart’ format makes it cost effective and suitable for various levels of workload.

www.bindingsite.co.uk